GovChime

Department of Health and Human Services: NAICS 541711 Research and development in biotechnology

In FY2026 (provisional), Department of Health and Human Services recorded $230.63M in net obligations under NAICS 541711 across 13 awards and orders.

FY2026 net obligations (provisional)
$230.63M
FY2026 awards and orders
13
FY2026 vendors
9
FY2027 to date
-$120.16K
0 awards and orders so far

Top vendors, FY2026

  1. 1. REGENERON PHARMACEUTICALS INC (TARRYTOWN, NY)$279.40M · 1
  2. 2. EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. (Gaithersburg, MD)$23.98M · 1
  3. 3. HOFFMANN-LA ROCHE INC. (LITTLE FALLS, NJ)$8.10M · 1
  4. 4. The Emmes Company, LLC (ROCKVILLE, MD)$4.73M · 1
  5. 5. BATTELLE MEMORIAL INSTITUTE (COLUMBUS, OH)$1.67M · 4
  6. 6. UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON (GALVESTON, TX)$1.60M · 1
  7. 7. TRUSTEES OF TUFTS COLLEGE (BOSTON, MA)$387.37K · 1
  8. 8. UNIVERSITY OF ALABAMA AT BIRMINGHAM (BIRMINGHAM, AL)$318.03K · 1
  9. 9. LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER (Torrance, CA)$224.33K · 1

Where its vendors are headquartered

$277.89M
New York (1 awards and orders)
$28.11M
Maryland (2 awards and orders)
$1.67M
Ohio (4 awards and orders)
$1.59M
Texas (1 awards and orders)
$387.37K
Massachusetts (1 awards and orders)
$318.03K
Alabama (1 awards and orders)

Net obligations by fiscal year of action, from FPDS contract actions under NAICS 541711. The agency is the awarding department. Awards and orders count canonical awards with a positive net in the year; IDV vehicles are not counted. FY2026 is provisional for 120 days after it ends, and DoD withholds awards for 90 days at the source. Methodology